## WMT: Walmart Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 1.6% below STRENGTH zone (3.0-6.0%); PEG 3.37 fails VALUE criteria (<1.0); RSI 70 overbought. Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.9% MRS), overbought RSI (70).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($110.52)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Costco Holds Steady While Walmart Bets Big on E-Commerce Transformation**
- Source: 24/7 Wall St. | 20251207T130905 | Bullish | Relevance: 98%
-  While Costco maintains its membership warehouse model and steady growth, Walmart is aggressively investing in its e-commerce and omnichannel transformation. Walmart shows significantly higher e-commerce and net income growth, trading at a lower P/E ratio than Costco despite its rapid expansion. The article suggests Walmart is a more compelling option for growth investors, while Costco remains a solid choice for defensive investors.

**2. Which stores are offering extended holiday hours? See Best Buy, Target hours and more**
- Source: The Courier-Journal | 20251209T030957 | Neutral | Relevance: 95%
-  Many major retailers are extending their hours for the 2025 holiday shopping season, primarily through December 23rd. Target stores will be open from 7 a.m. until midnight, while HomeGoods and Marshalls are extending hours to 8 a.m. to 11 p.m. daily. Walmart, however, has not announced special extended hours for the season.

**3. Recapping 2025’s flurry of major CEO moves**
- Source: Grocery Dive | 20251208T151912 | Neutral | Relevance: 92%
- The grocery industry saw a significant number of CEO changes in 2025, affecting major players like Kroger, Albertsons, Walmart, and Aldi. This article highlights key leadership transitions, including Rodney McMullen's resignation from Kroger and Vivek Sankaran's retirement from Albertsons, underscoring a busy year for top executive roles in the sector.

**4. Best Stock to Buy Right Now: Walmart vs. Target**
- Source: Finviz | 20251208T220856 | Somewhat-Bullish | Relevance: 92%
-  This article compares Walmart (WMT) and Target (TGT) as investment opportunities, highlighting their current valuations and business performance. While Walmart is performing strongly and its stock is near an all-time high, its valuation is considered expensive. Conversely, Target's stock has declined significantly, making it appear cheap, despite current underperformance, with the potential for a turnaround given its Dividend King status.

**5. Florida hospitals' opioid case against Walmart, CVS, Walgreens results in mistrial**
- Source: Reuters | 20251208T200823 | Neutral | Relevance: 85%
- A Florida judge declared a mistrial in a lawsuit brought by sixteen Florida hospitals against Walmart, CVS, and Walgreens, which accused the pharmacy chains of contributing to the opioid crisis in the state. The jurors deliberated for 14 days but could not reach a unanimous verdict in the case alleging the companies flooded the state with opioids and violated anti-racketeering laws. The hospitals claimed that the surge in opioid use led to injuries they had to treat, often without reimbursement, racking up significant unpaid bills.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 18, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Evercore ISI Gr | $117 | $115 | +2% |
| 2025-12-03 | Tigress Financi | $130 | $125 | +4% |
| 2025-11-21 | JP Morgan | $129 | $128 | +1% |
| 2025-11-21 | DA Davidson | $130 | $117 | +11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Evercore ISI Gr | main | Outperform |
| 2025-12-03 | Tigress Financi | main | Buy |
| 2025-11-21 | JP Morgan | main | Overweight |
| 2025-11-21 | DA Davidson | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 10 ($0.34M) |
| Sells | 31 ($572.86M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 19.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 5.5% (+0.9%)
- Blackrock Inc.: 4.3% (+0.4%)
- JPMORGAN CHASE & CO: 2.9% (+137.3%)
- State Street Corpora: 2.3% (+1.2%)
- Geode Capital Manage: 1.2% (+2.0%)

### Key Risks

1. Heavy insider selling: $573M sold (31 transactions in 90 days).
2. Valuation stretched: PEG 3.4x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 18 raises (avg +6%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 3.37 signals overvaluation risk, limited margin of safety. Forward P/E 38.8x stretched relative to 13% growth. Quality metrics strong (ROE 24%). Analyst sentiment positive (18 raises, avg +6%). Insider selling cluster ($572.9M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $917.4B |
| Beta | 0.64 |
| 52W Range | $79.81 - $116.27 |
| Short Interest | 0.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.37 |
| Forward P/E | 38.8 |
| Current P/E | 43.6 |
| YoY Growth | 12.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.5% to 1.6% (-1.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.4pp (needs >3.0% for momentum thesis). MRS_5 at 0.2% confirms short-term momentum alignment. Outperforming sector by 3.6pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.86), confirming momentum. RSI overbought at 70, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.63% (CS: 74) | Neutral |
| RSI_14 | 70.3 | Overbought |
| MACD Histogram | 0.86 | Bullish |
| vs SMA20 | 1.067x | Above |
| vs SMA50 | 1.092x | Above |
| vs SMA200 | 1.169x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $115.06
- **Stop Loss:** $110.52 (3.9% risk)
- **Target:** $119.60 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 110
- **Position Value:** $12,656.60
- **Portfolio %:** 12.66%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-19 (Est: $0.72)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.60 | $0.62 | +3.1% |
| 2025Q3 | $0.74 | $0.68 | -8.0% |
| 2025Q2 | $0.58 | $0.61 | +5.6% |
| 2025Q1 | $0.65 | $0.66 | +2.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*